Medical News

RSS

Helix BioPharma reports Phase II clinical results of Topical Interferon Alpha-2b for ano-genital warts

Helix BioPharma Corp. today announced results from the Phase II clinical trial assessing the efficacy and safety of Topical Interferon Alpha-2b cream for the treatment of ano-genital warts (AGW).

9 Jun 2010

Ontario's Community Pharmacies Coalition reacts to new regulations and vows to fight for patient care

Ontario's Community Pharmacies Coalition are extremely disappointed by yesterday's announcement by Health Minister Deb Matthews and the posting of amendments to regulations under the OBDA and DIDFA as it all but assures that Ontario patients will be less able to freely access the front-line community healthcare they have come to rely on.

9 Jun 2010

Harvard and University of Montreal researchers challenge views on how cells respond to stimuli

People have them, cats have them and whales have some, too. Neurons, those interlinked nerve cells that carry sensations including pain, stretch from our spinal cords to the tips of our toes, paws or fins. According to a new study published in the journal Cell, scientists from the Harvard Medical School, the University of Montreal and the Dana-Farber Cancer Institute have found a new way by which nerve cells relay information that tell them to grow from millimeters to meters in length.

9 Jun 2010

IBM, ProtonMedia enter teaming agreement for 3-D virtual collaboration platform

IBM and ProtonMedia have entered into a teaming agreement that will result in the delivery of innovative, 3-D virtual collaboration and communication solutions engineered specifically for global life sciences organizations. Under the terms of the agreement, ProtonMedia's ProtoSphere technology will be the basis for customized, 3-D virtual collaboration environments to create high-performance workplaces.

9 Jun 2010

Research findings hold promise for debilitating emotional symptoms of FXS

The study, which appears in the journal the Proceedings of the National Academy of Sciences, is also of potential therapeutic significance-it showed that a brief pharmacological treatment is capable of correcting some of these synaptic deficits in mice genetically engineered to model FXS.

9 Jun 2010

Experimental drug ipilimumab increases overall survival in patients with metastatic melanoma: Study

The Melanoma Network of Canada is excited with the new hope that long-anticipated results of a late-stage skin cancer trial brings to patients with advanced melanoma. The results, presented at the American Society of Clinical Oncology annual meeting, show increased survival with the experimental treatment ipilimumab in patients with previously-treated metastatic melanoma, the most deadly form of skin cancer.

9 Jun 2010

CPAP therapy effective at recouping memory abilities impaired by obstructive sleep apnea

Continuous positive airway pressure therapy helps restore memory consolidation in adults with obstructive sleep apnea, suggests a research abstract that will be presented Wednesday, June 9, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC.

9 Jun 2010

LAB Research completes exclusive radiotherapy partnership with DMV

LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced that it has completed an exclusive radiotherapy partnership with DMV Veterinary Centre creating a dedicated research platform.

9 Jun 2010

Discovery Labs receives FDA guidance to gain Surfaxin approval for RDS in premature infants

Discovery Laboratories, Inc. announces today that it has received written guidance from the U.S. Food and Drug Administration (FDA) that is consistent with its ongoing, comprehensive preclinical program to resolve the sole remaining chemistry, manufacturing & control (CMC) issue necessary to potentially gain FDA marketing approval for Surfaxin® (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants.

9 Jun 2010

Psychological intervention program teaches breast cancer patients how to cope with the disease

A psychological intervention program designed for breast cancer patients reduces the risk of dying if the cancer recurs, new research shows. The study is the latest in a series at Ohio State University that have shown that an intervention program that teaches patients how to cope with the disease can boost their health, well-being and even their chances of survival.

9 Jun 2010

Fluidigm develops world's first reusable bio-chip architecture

Fluidigm Corporation today announced it has developed the world's first reusable bio-chip architecture for the commercial market. These reusable integrated fluidic circuits (IFCs) will dramatically lower SNP genotyping costs and are designed to support accelerated sample throughput, while maintaining data quality of 99.75 percent or greater accuracy and 99 percent or greater call rates.

9 Jun 2010

GE Capital provides Schumacher Group $120M in senior secured credit facilities

GE Capital, Healthcare Financial Services provided, as administrative agent, $120 million in senior secured credit facilities to Schumacher Group, the third largest company serving the outsourcing emergency services management industry. The credit facilities will be used to provide the company with additional growth capital and to refinance existing indebtedness. GE Capital Markets served as lead arranger.

9 Jun 2010

Insulin delivery devices help diabetic patients optimize blood glucose control, minimize chronic health problems

The growing use of insulin delivery devices such as pens and pumps may help individuals with diabetes optimize blood glucose control and minimize their risk for chronic health problems associated with diabetes, as described in a Special Supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc.

9 Jun 2010

EMSC acquires CPPA anesthesia services companies

Emergency Medical Services Corporation announced that it has completed its acquisition of the anesthesia services companies associated with Clinical Partners, P.A. (CPPA). AnesthesiaCare has been providing management services to CPPA providers since purchasing management services and billing entities from CPPA in 2008. The CPPA anesthesia services companies are now a part of AnesthesiaCare.

9 Jun 2010

Switching to healthier diet can slow or reverse cognitive impairment in patients with Alzheimer's Disease: Study

Patients in the early to moderate stages of Alzheimer's Disease could have their cognitive impairment slowed or even reversed by switching to a healthier diet, according to researchers at Temple University.

9 Jun 2010

PharmaMar commences Aplidin Phase III registration trial for multiple myeloma

PharmaMar SA today announced that a registration trial in relapsed/refractory multiple myeloma patients has been initiated with Aplidin(R) (plitidepsin) in combination with dexamethasone versus dexamethasone alone.

9 Jun 2010

Global Fund to Fight AIDS, Tuberculosis and Malaria demonstrates strong progress in prevention, treatment

Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.8 million people on treatment for HIV/AIDS, 7 million people have been treated for tuberculosis and 122 million insecticide-treated nets have been distributed to prevent malaria infection.

9 Jun 2010

Siemens Healthcare to resell SSI's ClickON LinX technology

The SSI Group, Inc. (SSI) announced today that they have entered into a Value-Added Reseller agreement with Siemens Healthcare, Malvern, PA. The agreement enables Siemens Healthcare to sell SSI's industry leading ClickON® LinX technology, which provides patient claims editing and transmission for healthcare providers.

9 Jun 2010

Lubiprostone phase 3 clinical trial in Japan for chronic idiopathic constipation meets primary endpoint

Sucampo Pharmaceuticals, Inc. and Abbott today announced that a pivotal phase 3 clinical trial of lubiprostone for chronic idiopathic constipation (CIC) in Japanese patients met its primary endpoint with statistical significance and demonstrated a safety profile consistent with previously reported clinical lubiprostone data.

9 Jun 2010

TransTech Pharma, Forest Laboratories Holdings agree to develop and commercialize GKA compounds

TransTech Pharma, Inc and Forest Laboratories, Inc., today announced that TransTech Pharma and Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. have entered into a license agreement for the development and commercialization of small molecule compounds discovered and developed by TransTech Pharma.

9 Jun 2010

Medical News

Helix BioPharma reports Phase II clinical results of Topical Interferon Alpha-2b for ano-genital warts

Ontario's Community Pharmacies Coalition reacts to new regulations and vows to fight for patient care

Harvard and University of Montreal researchers challenge views on how cells respond to stimuli

IBM, ProtonMedia enter teaming agreement for 3-D virtual collaboration platform

Research findings hold promise for debilitating emotional symptoms of FXS

Experimental drug ipilimumab increases overall survival in patients with metastatic melanoma: Study

CPAP therapy effective at recouping memory abilities impaired by obstructive sleep apnea

LAB Research completes exclusive radiotherapy partnership with DMV

Discovery Labs receives FDA guidance to gain Surfaxin approval for RDS in premature infants

Psychological intervention program teaches breast cancer patients how to cope with the disease

Fluidigm develops world's first reusable bio-chip architecture

GE Capital provides Schumacher Group $120M in senior secured credit facilities

Insulin delivery devices help diabetic patients optimize blood glucose control, minimize chronic health problems

EMSC acquires CPPA anesthesia services companies

Switching to healthier diet can slow or reverse cognitive impairment in patients with Alzheimer's Disease: Study

PharmaMar commences Aplidin Phase III registration trial for multiple myeloma

Global Fund to Fight AIDS, Tuberculosis and Malaria demonstrates strong progress in prevention, treatment

Siemens Healthcare to resell SSI's ClickON LinX technology

Lubiprostone phase 3 clinical trial in Japan for chronic idiopathic constipation meets primary endpoint

TransTech Pharma, Forest Laboratories Holdings agree to develop and commercialize GKA compounds

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News